PARATEK PHARMACEUTICALS INC (PRTK)
US6993743029 - Common Stock
| MRQ (2023-6-30) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | 2019 (2019-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||
| Current Assets | ||||||||
| Cash | N/A | N/A | N/A | N/A | N/A | |||
| Cash Equivalents | 42.69M | 34.25M | 80.37M | 105.20M | 102.30M | |||
| Marketable Securities | N/A | 0.00 | 15.11M | 20.00M | 113.10M | |||
| Receivables | 42.51M | 78.04M | 33.12M | 15.70M | 9.60M | |||
| Inventories | 11.41M | 16.57M | 11.02M | 14.60M | 11.60M | |||
| Other Current Assets | 8.62M | 7.99M | 12.49M | 8.70M | 6.80M | |||
| Total Current Assets | 105.23M | 136.84M | 152.10M | 164.10M | 243.40M | |||
| Non-Current Assets | ||||||||
| PPE Net | 2.20M | 2.40M | 2.55M | 3.00M | 3.70M | |||
| Investments And Advances | N/A | N/A | N/A | N/A | 0.00 | |||
| Goodwill | 829.00K | 829.00K | 829.00K | 800.00K | 800.00K | |||
| Intangibles | N/A | N/A | N/A | N/A | N/A | |||
| Other Non-Current Assets | 37.54M | 32.47M | 28.39M | 8.90M | 3.20M | |||
| Total Non-Current Assets | 40.56M | 35.70M | 31.77M | 12.80M | 7.70M | |||
| TOTAL ASSETS | 145.79M | 172.54M | 183.87M | 176.90M | 251.10M | |||
| LIABILITIES | ||||||||
| Current Liabilities | ||||||||
| Short Term Debt | 164.04M | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Accrued Expenses | 35.20M | 31.71M | 24.05M | 21.60M | 17.70M | |||
| Accounts Payable | 2.95M | 5.31M | 5.39M | 1.80M | 4.10M | |||
| Other Current Liabilities | 423.00K | 370.00K | 1.86M | 500.00K | 2.40M | |||
| Total Current Liabilities | 202.62M | 37.39M | 31.30M | 24.00M | 24.20M | |||
| Non-Current Liabilities | ||||||||
| Long Term Debt | 94.28M | 256.95M | 254.43M | 250.50M | 260.70M | |||
| Other Non-Current Liabilities | 50.25M | 49.25M | 25.93M | 4.70M | 5.80M | |||
| Total Non-Current Liabilities | 144.54M | 306.19M | 280.36M | 255.10M | 266.50M | |||
| TOTAL LIABILITIES | 347.16M | 343.58M | 311.66M | 279.10M | 290.70M | |||
| SHAREHOLDERS' EQUITY | ||||||||
| Retained Earnings | -965.14M | -930.45M | -866.88M | -807.80M | -711.30M | |||
| Additional Paid In Capital | 763.72M | 759.35M | 739.05M | 705.50M | 671.50M | |||
| Common Shares | 57.00K | 56.00K | 52.00K | 0.00 | 0.00 | |||
| Other Shareholders' Equity | N/A | 0.00 | -9.00K | 0.00 | 100.00K | |||
| Shares Outstanding | 57.28M | 56.65M | 51.71M | 46.50M | 39.80M | |||
| Tangible Book Value per Share | -3.53 | -3.03 | -2.49 | -2.22 | -1.02 | |||
| Total Shareholders' Equity | -201.37M | -171.04M | -127.79M | -102.30M | -39.60M | |||
| TOTAL LIABILITIES AND EQUITY | 145.79M | 172.54M | 183.87M | 176.90M | 251.10M | |||
| Statistics | ||||||||
| Debt/Equity | -1.28 | -1.50 | -1.99 | -2.45 | -6.58 | |||
| Current Ratio | 0.52 | 3.66 | 4.86 | 6.84 | 10.06 | |||
| Return On Assets (ROA) | -43.03% | -36.84% | -32.13% | -54.57% | -51.29% | |||
| Return On Equity (ROE) | N/A | N/A | N/A | N/A | N/A | |||
All data in USD